CoreAge Rx vs MyDrHank
Two GLP-1 desks, one scoreboard. We put CoreAge Rx and MyDrHank head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 74 on our six-factor Brief Score — The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
That doesn't make MyDrHank a bad call — it's best for readers who already intend to prepay a year up front and want one account covering glp-1 alongside nad+, sermorelin and four other lines — and who will check the term attached to a price before treating it as a monthly bill. Weigh the six factors below against your own priorities before you decide.
Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| CoreAge Rx | MyDrHank | |
|---|---|---|
| Brief Score | 94/100 (A) | 74/100 (C) |
| Semaglutide | $99/mo | $259/mo (month-to-month; prepay tiers lower) |
| Tirzepatide | $149/mo | $349/mo (month-to-month; prepay tiers lower) |
| Coverage | All 50 states | 44 states (not KS, LA, MS, NM, ND, WV) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.
MyDrHank: First reading. The funnel advertises "from $240" tirzepatide and "from $171" semaglutide; both are twelve-month prepay rungs, and the month-to-month rates — $349 and $259 — appear on no page of it.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.